Loading…

Abstract 5501: Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells

Docetaxel-based chemotherapy prolongs life and relieves symptoms in patients with castration resistant prostate cancer. However, this needs to be improved because of limitations by lack of specificity, systemic toxicity, and progression of docetaxel-resistance. Nanotechnology has served a new role i...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2014-10, Vol.74 (19_Supplement), p.5501-5501
Main Authors: Furuta, Nao, Yamaguchi, Sou, Iwasaki, Ayumi, Okamoto, Daiki, Sato, Akiko, Endo, Yoshihiro, Kurioka, Daisuke, Nittami, Tadashi, Ishiguro, Hitoshi, Uemura, Hiroji, Kunota, Yoshinobu, Watanabe, Masatoshi
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 5501
container_issue 19_Supplement
container_start_page 5501
container_title Cancer research (Chicago, Ill.)
container_volume 74
creator Furuta, Nao
Yamaguchi, Sou
Iwasaki, Ayumi
Okamoto, Daiki
Sato, Akiko
Endo, Yoshihiro
Kurioka, Daisuke
Nittami, Tadashi
Ishiguro, Hitoshi
Uemura, Hiroji
Kunota, Yoshinobu
Watanabe, Masatoshi
description Docetaxel-based chemotherapy prolongs life and relieves symptoms in patients with castration resistant prostate cancer. However, this needs to be improved because of limitations by lack of specificity, systemic toxicity, and progression of docetaxel-resistance. Nanotechnology has served a new role in medical sciences by a variety of nanotechnology platforms, leading to theranostics. Among these platforms, Fe3O4 magnetic nanoparticles (MgNPs) have potential applications in drug delivery, cancer diagnosis and hyperthermia. We have already shown that MgNPs would modify the effect of chemotherapy in prostate cancer cells based on the observations that MgNPs increased reactive oxygen species (ROS) production and induced oxidative DNA damage in prostate cancer cell lines. Combined treatment of docetaxel and MgNPs has also shown to suppress nuclear transcription factor kappa B expression in DU145 cells. In this study, we analyzed the combined effects of docetaxel-MgNPs with different surface modifications on a prostate cancer cell line, DU145 and their mechanisms. The combination treatment of docetaxel and carboxylic acid-modified MgNPs (MgNPs-COOH) more effectively inhibited cancer cell growth and induced apoptosis compared with docetaxel-MgNPs combination. While MgNPs produced ROS in a dose-dependent manner and inhibited cancer cell growth slightly, MgNPs-COOH did exert no ROS production, however cell membrane damage in a dose-dependent manner. In addition, MgNPs-COOH showed the involvement of the endoplasmic reticulum (ER) stress. These results suggest that MgNPs-COOH may induce different responses compared with MgNPs, and result in favorable development of current chemotherapy for the advanced disease and leading to new theranostics. Citation Format: Nao Furuta, Sou Yamaguchi, Ayumi Iwasaki, Daiki Okamoto, Akiko Sato, Yoshihiro Endo, Daisuke Kurioka, Tadashi Nittami, Hitoshi Ishiguro, Hiroji Uemura, Yoshinobu Kunota, Masatoshi Watanabe. Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5501. doi:10.1158/1538-7445.AM2014-5501
doi_str_mv 10.1158/1538-7445.AM2014-5501
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1158_1538_7445_AM2014_5501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1158_1538_7445_AM2014_5501</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1158_1538_7445_AM2014_55013</originalsourceid><addsrcrecordid>eNqdj8FKBDEMhosoOK4-gpAX6NruTtnB27IoXrx5L9lMqpVOO7QV9eib20HxATwl-ckX8glxrdVaazPcaLMd5K7vzXr_uFG6l8YofSK6v_xUdEqpQZp-tzkXF6W8ttFoZTrxtT-WmpEqLNAtHNJ09JFHYOeYaoHkYEzEFT84yAmfI1dPEDGmGXNrAxd49_UFRt-IzLFCecsOiWFKLfOE1afYDkWYcyoVKwNhJM5AHEK5FGcOQ-Gr37oS5v7u6fAgqW2XzM7O2U-YP61WdvG1i5ddvOyPr11e3_6X-wbtlGEy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Abstract 5501: Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells</title><source>EZB*</source><creator>Furuta, Nao ; Yamaguchi, Sou ; Iwasaki, Ayumi ; Okamoto, Daiki ; Sato, Akiko ; Endo, Yoshihiro ; Kurioka, Daisuke ; Nittami, Tadashi ; Ishiguro, Hitoshi ; Uemura, Hiroji ; Kunota, Yoshinobu ; Watanabe, Masatoshi</creator><creatorcontrib>Furuta, Nao ; Yamaguchi, Sou ; Iwasaki, Ayumi ; Okamoto, Daiki ; Sato, Akiko ; Endo, Yoshihiro ; Kurioka, Daisuke ; Nittami, Tadashi ; Ishiguro, Hitoshi ; Uemura, Hiroji ; Kunota, Yoshinobu ; Watanabe, Masatoshi</creatorcontrib><description>Docetaxel-based chemotherapy prolongs life and relieves symptoms in patients with castration resistant prostate cancer. However, this needs to be improved because of limitations by lack of specificity, systemic toxicity, and progression of docetaxel-resistance. Nanotechnology has served a new role in medical sciences by a variety of nanotechnology platforms, leading to theranostics. Among these platforms, Fe3O4 magnetic nanoparticles (MgNPs) have potential applications in drug delivery, cancer diagnosis and hyperthermia. We have already shown that MgNPs would modify the effect of chemotherapy in prostate cancer cells based on the observations that MgNPs increased reactive oxygen species (ROS) production and induced oxidative DNA damage in prostate cancer cell lines. Combined treatment of docetaxel and MgNPs has also shown to suppress nuclear transcription factor kappa B expression in DU145 cells. In this study, we analyzed the combined effects of docetaxel-MgNPs with different surface modifications on a prostate cancer cell line, DU145 and their mechanisms. The combination treatment of docetaxel and carboxylic acid-modified MgNPs (MgNPs-COOH) more effectively inhibited cancer cell growth and induced apoptosis compared with docetaxel-MgNPs combination. While MgNPs produced ROS in a dose-dependent manner and inhibited cancer cell growth slightly, MgNPs-COOH did exert no ROS production, however cell membrane damage in a dose-dependent manner. In addition, MgNPs-COOH showed the involvement of the endoplasmic reticulum (ER) stress. These results suggest that MgNPs-COOH may induce different responses compared with MgNPs, and result in favorable development of current chemotherapy for the advanced disease and leading to new theranostics. Citation Format: Nao Furuta, Sou Yamaguchi, Ayumi Iwasaki, Daiki Okamoto, Akiko Sato, Yoshihiro Endo, Daisuke Kurioka, Tadashi Nittami, Hitoshi Ishiguro, Hiroji Uemura, Yoshinobu Kunota, Masatoshi Watanabe. Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5501. doi:10.1158/1538-7445.AM2014-5501</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/1538-7445.AM2014-5501</identifier><language>eng</language><ispartof>Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5501-5501</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids></links><search><creatorcontrib>Furuta, Nao</creatorcontrib><creatorcontrib>Yamaguchi, Sou</creatorcontrib><creatorcontrib>Iwasaki, Ayumi</creatorcontrib><creatorcontrib>Okamoto, Daiki</creatorcontrib><creatorcontrib>Sato, Akiko</creatorcontrib><creatorcontrib>Endo, Yoshihiro</creatorcontrib><creatorcontrib>Kurioka, Daisuke</creatorcontrib><creatorcontrib>Nittami, Tadashi</creatorcontrib><creatorcontrib>Ishiguro, Hitoshi</creatorcontrib><creatorcontrib>Uemura, Hiroji</creatorcontrib><creatorcontrib>Kunota, Yoshinobu</creatorcontrib><creatorcontrib>Watanabe, Masatoshi</creatorcontrib><title>Abstract 5501: Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells</title><title>Cancer research (Chicago, Ill.)</title><description>Docetaxel-based chemotherapy prolongs life and relieves symptoms in patients with castration resistant prostate cancer. However, this needs to be improved because of limitations by lack of specificity, systemic toxicity, and progression of docetaxel-resistance. Nanotechnology has served a new role in medical sciences by a variety of nanotechnology platforms, leading to theranostics. Among these platforms, Fe3O4 magnetic nanoparticles (MgNPs) have potential applications in drug delivery, cancer diagnosis and hyperthermia. We have already shown that MgNPs would modify the effect of chemotherapy in prostate cancer cells based on the observations that MgNPs increased reactive oxygen species (ROS) production and induced oxidative DNA damage in prostate cancer cell lines. Combined treatment of docetaxel and MgNPs has also shown to suppress nuclear transcription factor kappa B expression in DU145 cells. In this study, we analyzed the combined effects of docetaxel-MgNPs with different surface modifications on a prostate cancer cell line, DU145 and their mechanisms. The combination treatment of docetaxel and carboxylic acid-modified MgNPs (MgNPs-COOH) more effectively inhibited cancer cell growth and induced apoptosis compared with docetaxel-MgNPs combination. While MgNPs produced ROS in a dose-dependent manner and inhibited cancer cell growth slightly, MgNPs-COOH did exert no ROS production, however cell membrane damage in a dose-dependent manner. In addition, MgNPs-COOH showed the involvement of the endoplasmic reticulum (ER) stress. These results suggest that MgNPs-COOH may induce different responses compared with MgNPs, and result in favorable development of current chemotherapy for the advanced disease and leading to new theranostics. Citation Format: Nao Furuta, Sou Yamaguchi, Ayumi Iwasaki, Daiki Okamoto, Akiko Sato, Yoshihiro Endo, Daisuke Kurioka, Tadashi Nittami, Hitoshi Ishiguro, Hiroji Uemura, Yoshinobu Kunota, Masatoshi Watanabe. Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5501. doi:10.1158/1538-7445.AM2014-5501</description><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqdj8FKBDEMhosoOK4-gpAX6NruTtnB27IoXrx5L9lMqpVOO7QV9eib20HxATwl-ckX8glxrdVaazPcaLMd5K7vzXr_uFG6l8YofSK6v_xUdEqpQZp-tzkXF6W8ttFoZTrxtT-WmpEqLNAtHNJ09JFHYOeYaoHkYEzEFT84yAmfI1dPEDGmGXNrAxd49_UFRt-IzLFCecsOiWFKLfOE1afYDkWYcyoVKwNhJM5AHEK5FGcOQ-Gr37oS5v7u6fAgqW2XzM7O2U-YP61WdvG1i5ddvOyPr11e3_6X-wbtlGEy</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Furuta, Nao</creator><creator>Yamaguchi, Sou</creator><creator>Iwasaki, Ayumi</creator><creator>Okamoto, Daiki</creator><creator>Sato, Akiko</creator><creator>Endo, Yoshihiro</creator><creator>Kurioka, Daisuke</creator><creator>Nittami, Tadashi</creator><creator>Ishiguro, Hitoshi</creator><creator>Uemura, Hiroji</creator><creator>Kunota, Yoshinobu</creator><creator>Watanabe, Masatoshi</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20141001</creationdate><title>Abstract 5501: Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells</title><author>Furuta, Nao ; Yamaguchi, Sou ; Iwasaki, Ayumi ; Okamoto, Daiki ; Sato, Akiko ; Endo, Yoshihiro ; Kurioka, Daisuke ; Nittami, Tadashi ; Ishiguro, Hitoshi ; Uemura, Hiroji ; Kunota, Yoshinobu ; Watanabe, Masatoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1158_1538_7445_AM2014_55013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Furuta, Nao</creatorcontrib><creatorcontrib>Yamaguchi, Sou</creatorcontrib><creatorcontrib>Iwasaki, Ayumi</creatorcontrib><creatorcontrib>Okamoto, Daiki</creatorcontrib><creatorcontrib>Sato, Akiko</creatorcontrib><creatorcontrib>Endo, Yoshihiro</creatorcontrib><creatorcontrib>Kurioka, Daisuke</creatorcontrib><creatorcontrib>Nittami, Tadashi</creatorcontrib><creatorcontrib>Ishiguro, Hitoshi</creatorcontrib><creatorcontrib>Uemura, Hiroji</creatorcontrib><creatorcontrib>Kunota, Yoshinobu</creatorcontrib><creatorcontrib>Watanabe, Masatoshi</creatorcontrib><collection>CrossRef</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Furuta, Nao</au><au>Yamaguchi, Sou</au><au>Iwasaki, Ayumi</au><au>Okamoto, Daiki</au><au>Sato, Akiko</au><au>Endo, Yoshihiro</au><au>Kurioka, Daisuke</au><au>Nittami, Tadashi</au><au>Ishiguro, Hitoshi</au><au>Uemura, Hiroji</au><au>Kunota, Yoshinobu</au><au>Watanabe, Masatoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abstract 5501: Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><date>2014-10-01</date><risdate>2014</risdate><volume>74</volume><issue>19_Supplement</issue><spage>5501</spage><epage>5501</epage><pages>5501-5501</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><abstract>Docetaxel-based chemotherapy prolongs life and relieves symptoms in patients with castration resistant prostate cancer. However, this needs to be improved because of limitations by lack of specificity, systemic toxicity, and progression of docetaxel-resistance. Nanotechnology has served a new role in medical sciences by a variety of nanotechnology platforms, leading to theranostics. Among these platforms, Fe3O4 magnetic nanoparticles (MgNPs) have potential applications in drug delivery, cancer diagnosis and hyperthermia. We have already shown that MgNPs would modify the effect of chemotherapy in prostate cancer cells based on the observations that MgNPs increased reactive oxygen species (ROS) production and induced oxidative DNA damage in prostate cancer cell lines. Combined treatment of docetaxel and MgNPs has also shown to suppress nuclear transcription factor kappa B expression in DU145 cells. In this study, we analyzed the combined effects of docetaxel-MgNPs with different surface modifications on a prostate cancer cell line, DU145 and their mechanisms. The combination treatment of docetaxel and carboxylic acid-modified MgNPs (MgNPs-COOH) more effectively inhibited cancer cell growth and induced apoptosis compared with docetaxel-MgNPs combination. While MgNPs produced ROS in a dose-dependent manner and inhibited cancer cell growth slightly, MgNPs-COOH did exert no ROS production, however cell membrane damage in a dose-dependent manner. In addition, MgNPs-COOH showed the involvement of the endoplasmic reticulum (ER) stress. These results suggest that MgNPs-COOH may induce different responses compared with MgNPs, and result in favorable development of current chemotherapy for the advanced disease and leading to new theranostics. Citation Format: Nao Furuta, Sou Yamaguchi, Ayumi Iwasaki, Daiki Okamoto, Akiko Sato, Yoshihiro Endo, Daisuke Kurioka, Tadashi Nittami, Hitoshi Ishiguro, Hiroji Uemura, Yoshinobu Kunota, Masatoshi Watanabe. Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5501. doi:10.1158/1538-7445.AM2014-5501</abstract><doi>10.1158/1538-7445.AM2014-5501</doi></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5501-5501
issn 0008-5472
1538-7445
language eng
recordid cdi_crossref_primary_10_1158_1538_7445_AM2014_5501
source EZB*
title Abstract 5501: Combined effects of docetaxel-magnetic nanoparticles with different surface modifications on prostate cancer cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T20%3A51%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abstract%205501:%20Combined%20effects%20of%20docetaxel-magnetic%20nanoparticles%20with%20different%20surface%20modifications%20on%20prostate%20cancer%20cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Furuta,%20Nao&rft.date=2014-10-01&rft.volume=74&rft.issue=19_Supplement&rft.spage=5501&rft.epage=5501&rft.pages=5501-5501&rft.issn=0008-5472&rft.eissn=1538-7445&rft_id=info:doi/10.1158/1538-7445.AM2014-5501&rft_dat=%3Ccrossref%3E10_1158_1538_7445_AM2014_5501%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_1158_1538_7445_AM2014_55013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true